BetterLife Provides Important Update on its Australian Clinical Study Design
Go back to BetterLife Provides Important Update on its Australian Clinical Study Design| (NASDAQ: BETR) | Delayed: 12.42 +0.36 (2.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.06 | 52 Week High | $17.53 | |||
| Open | $12.37 | 52 Week Low | $9.15 | |||
| Day High | $12.77 | P/E | N/A | |||
| Day Low | $12.09 | EPS | $0.00 | |||
| Volume | 391,925 | |||||
| (AMEX: BETRF) | Delayed: 0.22 -0.03 (12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.25 | 52 Week High | $ | |||
| Open | $0.23 | 52 Week Low | $ | |||
| Day High | $0.24 | P/E | N/A | |||
| Day Low | $0.21 | EPS | $ | |||
| Volume | 148,182 | |||||
